POLYMORPHISMS NEAR THE IL28B GENE ARE NOT ASSOCIATED WITH RESPONSE TO PEGINTERFERON IN HBeAg-NEGATIVE CHRONIC HEPATITIS B PATIENTS

被引:4
|
作者
Brouwer, W. P. [1 ]
Arends, P. [1 ]
Rijckborst, V. [1 ]
ter Borg, M. J. [1 ]
Cakaloglu, Y. [2 ]
Ferenci, P. [3 ]
Tabak, F. [4 ]
Akdogan, M. [5 ]
Simon, K. [6 ]
Raptopoulou-Gigi, M. [7 ]
Ormeci, N. [8 ]
Akarca, U. S. [9 ]
Flisiak, R. [10 ]
Hansen, B. [1 ]
Boonstra, A. [1 ]
Janssen, H. L. A. [1 ]
机构
[1] Univ Med Ctr Rotterdam, Erasmus MC, Rotterdam, Netherlands
[2] Istanbul Fac Med, Istanbul, Turkey
[3] Med Univ Vienna, Vienna, Austria
[4] Cerrahpasa Med Fac, Istanbul, Turkey
[5] Turkiye Yuksek Ihtisas Hastanes, Ankara, Turkey
[6] Katedra & Klin Chorob Zakaznych, Wroclaw, Poland
[7] Aristotel Univ Thessaloniki, Thessaloniki, Greece
[8] Ankara Univ, Sch Med, Ibn I Sina Hosp, TR-06100 Ankara, Turkey
[9] Ege Univ, Tip Fak, Bornova, Turkey
[10] Med Univ Bialystok, Bialystok, Poland
关键词
D O I
10.1016/S0168-8278(13)60739-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
737
引用
收藏
页码:S299 / S299
页数:1
相关论文
共 50 条
  • [21] Interleukin-28 gene polymorphisms may contribute to HBsAg persistence and the development of HBeAg-negative chronic hepatitis B
    Karatayli, Senem C.
    Bozdayi, Mithat
    Karatayli, Ersin
    Ozturk, Tugba
    Husseini, Abbas A.
    Albayrak, Rabia
    Ozkan, Muhip
    Kalaylioglu, Zeynep
    Yalcin, Kendal
    Cinar, Kubilay
    Idilman, Ramazan
    Yurdaydin, Cihan
    LIVER INTERNATIONAL, 2015, 35 (03) : 846 - 853
  • [22] Impaired IL28B gene induction and poor IL28B promoter activity influenced by the IL28B minor allele are closely associated with a null response to interferon in chronic hepatitis C patients
    Asahina, Yasuhiro
    Murakawa, Miyako
    Sakamoto, Naoya
    Kakinuma, Sei
    Nakagawa, Mina
    Azuma, Seishin
    Nishimura-Sakurai, Yuki
    Nitta, Sayuri
    Kusano-Kitazume, Akiko
    Watanabe, Mamoru
    HEPATOLOGY, 2012, 56 : 697A - 698A
  • [23] Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B
    Bonino, F.
    Marcellin, P.
    Lau, G. K. K.
    Hadziyannis, S.
    Jin, R.
    Piratvisuth, T.
    Germanidis, G.
    Yurdaydin, C.
    Diago, M.
    Gurel, S.
    Lai, M-Y
    Brunetto, M. R.
    Farci, P.
    Popescu, M.
    McCloud, P.
    GUT, 2007, 56 (05) : 699 - 705
  • [24] IL28B POLYMORPHISM IS NOT ASSOCIATED WITH RESPONSE TO CONVENTIONAL INTERFERON TREATMENT AND HBSAG SEROCLEARANCE IN HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS
    Lada, O.
    Zhang, Q.
    Lapalus, M.
    Moucari, R.
    De Muynck, S.
    Martinot-Peignoux, M.
    Bieche, I.
    Laouenan, C.
    Estrabaud, E.
    Boyer, N.
    Vidaud, M.
    Asselah, T.
    Marcellin, P.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S177 - S177
  • [25] Peginterferon Therapy for HBeAg-Negative Chronic Hepatitis B: Less Than Meets the Eye
    Dienstag, Jules L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (08): : 1770 - 1772
  • [26] On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients
    Goulis, Ioannis
    Karatapanis, Stylianos
    Akriviadis, Evangelos
    Deutsch, Melanie
    Dalekos, George N.
    Raptopoulou-Gigi, Maria
    Mimidis, Konstantinos
    Germanidis, George
    Drakoulis, Christos
    Triantos, Christos
    Zintzaras, Elias
    Bakalos, Georgios
    Papatheodoridis, George
    LIVER INTERNATIONAL, 2015, 35 (05) : 1540 - 1548
  • [27] Studies of IL28B Genotype and Response to Peginterferon in Chronic Hepatitis B Should Be Stratified by HBV Genotype
    Lampertico, Pietro
    Galmozzi, Enrico
    Colombo, Massimo
    HEPATOLOGY, 2013, 57 (03) : 1283 - 1284
  • [28] IL28B POLYMORPHISMS ARE NOT ASSOCIATED WITH OUTCOMES OF HEPATITIS B VIRUS INFECTION
    Park, Neung Hwa
    Kim, Chang Jae
    HEPATOLOGY, 2011, 54 : 1094A - 1094A
  • [29] Response-guided peginterferon therapy for hbeag-positive and hbeag-negative chronic hepatitis b using hepatitis b surface antigen levels: A review
    Sonneveld M.J.
    Brouwer W.P.
    Janssen H.L.A.
    Current Hepatology Reports, 2014, 13 (3) : 250 - 255
  • [30] Treatment paradigms in hepatitis B e antigen negative (HBeAg-negative) chronic hepatitis B patients
    Hadziyannis, S. J.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S15 - S15